[1] 乐杰. 妇产科学[M]. 8版.北京:人民卫生出版社,2016:47-48. [2] KHAN K S,WOJDYLA D W,SAY L,et al.WHO analysis of causes of maternal death:a systematic review[J]. Lancet,2006, 367(9516):1066-1074. [3] DOUGLAS S A,DHANAK D,JOHNS D G.From 'gills to pills': urotensin-Ⅱ as a regulator of mammalian cardiorenal function[J]. Trends Pharmacol Sci,2004,25(2):76-85. [4] GIACHINI F R,CALLERA G E,CARNEIRO F S,et al.Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors?[J]. Expert Opin Ther Targets,2008,12(3):327-339. [5] KEMP W,ROBERTS S,KRUM H.Urotensin Ⅱ: a vascular mediator in health and disease[J]. Curr Vasc Pharmacol,2005,3(2):159-168. [6] 王小如,时庆,汪大琨,等. 尾加压素Ⅱ对大鼠肺动脉平滑肌细胞增殖及细胞外信号调节激酶1/2蛋白磷酸化的影响[J]. 山东大学学报(医学版),2011,49(12):13-17. [7] SCHLESSELMAN J J.Case-control studies:design, conduct,and analysis[M]. New York:Oxford University,1982. [8] PENG H,ZHANG M,CAI X,et al.Association between human urotensin Ⅱand essential hypertension-a 1:1 matched case-control study[J]. PLoS One,2013,8: e81764. [9] 吴文英,徐春琳. 妊娠期高血压疾病患者血清尾加压素Ⅱ对心脏形态及功能影响的研究[J]. 中国优生与遗传杂志,2008,16(2): 57-58. [10] 陈敏芝. 妊娠高血压综合征孕妇血浆尾加压素Ⅱ与血清C反应蛋白检测水平的临床意义[J]. 华南国防医学杂志,2011,25(1): 30-31. [11] LIM M,HONISETT S,SPARKES C D,et al.Differential effect of urotensin Ⅱ on vascular tone in normal subjects and patients with chronic heart failure[J]. Circulation,2004,109(10):1212-1214. [12] DOUGLAS S A,ASHTON D J,S AUERMELCH C F,et al. Human urotensin-Ⅱ is a potent vasoactive peptide: pharmacological characterization in the rat,mouse,dog and primate[J]. J Cardiovasc Pharmacol,2000,36(5 Suppl.1): 163-166. [13] CHEUNG B M,LEUNG R,MAN Y B,et al.Plasma concentration of urotensin Ⅱ is raised in hypetension[J]. J Hypertens,2004,22(7):1341-1344. [14] VAUDRY H,DOREGO J C,LEMEVEL J C,et al.Urotensin Ⅱ,from fish to human[J]. Ann N Y Acad Sci,2010,1200: 53-66. [15] MERLINO F,DIM S,MUNAIM Y A,et al.Urotensin-Ⅱligands: an overview from peptide to nonpeptide structures[J]. J Amino Acids,2013,2013:979016. [16] 陈敏芝. 尾加压素Ⅱ与C反应蛋白在妊娠期高血压疾病的作用[J]. 中华全科医学,2011,9(6):892-893. [17] 胡艳超,韩拓,贾珊,等. 尾加压素Ⅱ促进血管外膜成纤维细胞表达肿瘤坏死因子α及其机制[J]. 西安交通大学学报(医学版),2019,40(1):23-26,54. [18] TOTSUNE K,TAKAHASHI K,ARIHARA Z,et al.Increased plasma urotensin Ⅱ levels in patients with diabetes mellitus[J].Clin Sci(Lond),2003,104(1):1-5. [19] TOTSUNE K,TAKAHASHI K,ARIHARA Z,et al.Elevated plasma levels of immunoreactive urotensin Ⅱ and its increased urinary excretetion in patients with type 2 diabetes mellitus:association with progress of diabetic nephropathy[J]. Peptides,2004,25(10):1809-1814.
